192 related articles for article (PubMed ID: 2453906)
21. Pharmacokinetics of interferon in blood, cerebrospinal fluid, and brain after administration of modified polyriboinosinic-polyribocytidylic acid and amphotericin B.
Williams BB; Paul RT; Lerner AM
J Infect Dis; 1982 Dec; 146(6):819-25. PubMed ID: 6183371
[TBL] [Abstract][Full Text] [Related]
22. Modified polyriboinosinic-polyribocytidylic acid complex: induction of serum interferon, fever, and hypotension in rabbits.
Gatmaitan BG; Legaspi RC; Levy HB; Lerner AM
Antimicrob Agents Chemother; 1980 Jan; 17(1):49-54. PubMed ID: 7352750
[TBL] [Abstract][Full Text] [Related]
23. Poly ICLC induces anti-IC antibodies in mice and rabbits.
Granados EN; Alm T; O'Malley JA; McGarry M; Bello J
J Interferon Res; 1984; 4(1):57-62. PubMed ID: 6715915
[TBL] [Abstract][Full Text] [Related]
24. Historical overview of the use of polynucleotides in cancer.
Levy HB
J Biol Response Mod; 1985 Oct; 4(5):475-80. PubMed ID: 2416882
[TBL] [Abstract][Full Text] [Related]
25. Phase I-II trials of poly(ICLC) in malignant brain tumor patients.
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
J Interferon Res; 1982; 2(1):1-4. PubMed ID: 6180095
[TBL] [Abstract][Full Text] [Related]
26. Interferon induction and therapy of brain tumors in rats by poly(ICLC).
Machida H; Takezawa J; Kuninaka A; Yoshino H; Nakamura O; Takakura K
Microbiol Immunol; 1982; 26(4):353-8. PubMed ID: 6180284
[No Abstract] [Full Text] [Related]
27. Purification of carboxymethylcellulose decreases toxicity of poly ICLC in mice.
Bello J; O'Malley J; Granados E
J Interferon Res; 1985; 5(3):429-30. PubMed ID: 4056490
[TBL] [Abstract][Full Text] [Related]
28. Treatment of advanced ovarian cancer with polyinosinic-polycytidylic lysine carboxymethylcellulose (poly(ICLC)).
Rettenmaier MA; Berman ML; DiSaia PJ
Gynecol Oncol; 1986 Jul; 24(3):359-61. PubMed ID: 3721308
[TBL] [Abstract][Full Text] [Related]
29. [Effect of interferon inducer (poly ICLC) in the treatment of malignant brain tumor (author's transl)].
Nakamura O; Shitara N; Matsutani M; Takakura K; Machida H
No To Shinkei; 1982 Mar; 34(3):267-73. PubMed ID: 7093065
[TBL] [Abstract][Full Text] [Related]
30. Interferon induction with polyinosinic:polycytidylic acid in the newborn piglet.
Loewen KG; Derbyshire JB
Can J Vet Res; 1986 Apr; 50(2):232-7. PubMed ID: 2428457
[TBL] [Abstract][Full Text] [Related]
31. Lack of correlation between interferon levels induced by polyribonucleotides and their antimetastatic effect.
Sakurai M; Iigo M; Sasaki Y; Nakagawa K; Fujiwara Y; Tamura T; Ohe Y; Bungo M; Saijo N
Oncology; 1990; 47(3):251-6. PubMed ID: 1692985
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of polyinosinic-polycytidylic and poly-L-lysine in metastatic breast cancer.
Theriault RL; Hortobagyi GN; Buzdar AU; Levy HB; Hersh EM
Cancer Treat Rep; 1986 Nov; 70(11):1341-2. PubMed ID: 3768878
[No Abstract] [Full Text] [Related]
33. Polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose in combination with interleukin 2 in patients with cancer: clinical and immunological effects.
Ewel CH; Urba WJ; Kopp WC; Smith JW; Steis RG; Rossio JL; Longo DL; Jones MJ; Alvord WG; Pinsky CM
Cancer Res; 1992 Jun; 52(11):3005-10. PubMed ID: 1591717
[TBL] [Abstract][Full Text] [Related]
34. Interferon induction in cynomolgus and rhesus monkey after repeated doses of a modified polyriboinosinic-polyribocytidylic acid complex.
Sammons ML; Stephen EL; Levy HB; Baron S; Hilmas DE
Antimicrob Agents Chemother; 1977 Jan; 11(1):80-3. PubMed ID: 402107
[TBL] [Abstract][Full Text] [Related]
35. Interferon induction in dogs.
Tsai SC; Appel MJ
Am J Vet Res; 1979 Mar; 40(3):356-61. PubMed ID: 475087
[TBL] [Abstract][Full Text] [Related]
36. Initial clinical trials in cancer patients of polyriboinosinic-polyribocytidylic acid stabilized with poly-L-lysine, in carboxymethylcellulose [poly(ICLC)], a highly effective interferon inducer.
Levine AS; Sivulich M; Wiernik PH; Levy HB
Cancer Res; 1979 May; 39(5):1645-50. PubMed ID: 371793
[No Abstract] [Full Text] [Related]
37. Immune modulating effects of poly ICLC.
Levy HB; Lvovsky E; Riley F; Harrington D; Anderson A; Moe J; Hilfenhaus J; Stephen E
Ann N Y Acad Sci; 1980; 350():33-41. PubMed ID: 6972185
[No Abstract] [Full Text] [Related]
38. Killing of Leishmania donovani amastigotes by poly ICLC in hamsters.
Bhakuni V; Singha UK; Dutta GP; Levy HB; Maheshwari RK
J Interferon Cytokine Res; 1996 Apr; 16(4):321-5. PubMed ID: 9162526
[TBL] [Abstract][Full Text] [Related]
39. Biological characterization of MVE-2 and poly ICLC.
Schlick E; Welker R; Piccoli M; Ruffmann R; Chirigos M
Prog Clin Biol Res; 1984; 161():511-24. PubMed ID: 6483902
[No Abstract] [Full Text] [Related]
40. Modified polyriboinosinic-polyribocytidylic acid complex: modulation of toxicity for rabbits by alterations in components.
Gatmaitan BG; Levy HB; Lerner AM
Antimicrob Agents Chemother; 1980 Sep; 18(3):409-15. PubMed ID: 6158914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
